Subject(s)
Erythema Infectiosum/nursing , Nursing Diagnosis , Adolescent , Adult , Age Factors , Child , Child, Preschool , Diagnosis, Differential , Erythema Infectiosum/congenital , Erythema Infectiosum/diagnosis , Erythrocyte Aging , Female , Germany , Humans , Infant , Infant, Newborn , Pregnancy , Prognosis , Young AdultABSTRACT
Parvovirus B19 is an ubiquitous organism. Although for many years it had been "a virus in search of a disease," it is now known to be associated with several clinical entities ranging from the benign to severe. The most significant aspect of parvovirus B19 is its effect on the fetus. Research has demonstrated the risk, although minimal, of fetal loss to be between 1.5% to 2.5%. The effect from an emotional standpoint for the pregnant exposed or infected woman is more difficult to quantify. It is imperative that nurses who care for children be well informed about the virus and able to implement a comprehensive plan.
Subject(s)
Erythema Infectiosum/virology , Parvovirus B19, Human , Pregnancy Complications, Infectious/virology , Erythema Infectiosum/complications , Erythema Infectiosum/nursing , Female , Fetal Death , Humans , Patient Care Planning , Pediatric Nursing , Pregnancy , Pregnancy Complications, Infectious/nursingABSTRACT
Human parvovirus is an often unrecognized but potentially deadly infection when contracted by childbearing women who are seronegative. Although maternal symptoms and sequelae are mild, the exposed fetus quickly can develop nonimmune hydrops fetalis and die. Health care providers can prepare for appropriate maternal and fetal management by reviewing the history, disease process, and transmission mode of parvovirus.
